Rarebase launches a neuroscience drug discovery platform collaborating with 15 rare disease patient organizations

PALO ALTO, Calif.: PALO ALTO, Calif., Sept. 14, 2021 /PRNewswire/ -- Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function's 15 patient organization collaborators represent genes that cause epilepsy, autism, developmental delay and neurodegeneration. Learn more about the capabilities of Function here. "Function is...

Click to view original post